Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper B Andersen

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
European Journal of Biochemistry|January 20, 2004
Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1Jesper B Andersen, Dorthe J Strandbygård, Rune Hartmann, et al.
Journal of Hepatology|December 7, 2013
Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trendsMatthias S Matter, Thomas Decaens, Jesper B Andersen, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 25, 2017
Epigenome dysregulation in cholangiocarcinomaColm J O'Rourke, Patricia Munoz-Garrido, Esmeralda L Aguayo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2019
Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?Chiara Braconi, Stephanie Roessler, Beata Kruk, et al.
Insights Into Imaging|November 10, 2025
Critical dialogue: Can AI-based imaging predict tumor biology? Infer metastasis, microvascular invasion, and growth patterns from pixelsYashbir Singh, Gregory J Gores, Jesper B Andersen, et al.
RNA Biology|May 5, 2009
Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescenceJesper B Andersen, Krystyna Mazan-Mamczarz, Ming Zhan, et al.
Nature Reviews. Gastroenterology & Hepatology|November 1, 2019
Metabolic rearrangements in primary liver cancers: cause and consequencesLetizia Satriano, Monika Lewinska, Pedro M Rodrigues, et al.
Digestive Diseases (Basel, Switzerland)|May 13, 2016
Molecular Pathogenesis and Current Therapy in Intrahepatic CholangiocarcinomaDan Høgdall, Colm J O'Rourke, Andrzej Taranta, et al.
Expert Review of Gastroenterology & Hepatology|February 7, 2017
Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targetsDouglas V N P Oliveira, Shanshan Zhang, Xin Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Personalized Neoadjuvant Chemotherapy for Gastrointestinal Cancers: Shaping Imprecision to be PreciseDan Høgdall, Jakob V Schou, Julia Johanna Almer Bromann, et al.
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
European Journal of Biochemistry|January 20, 2004
Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1Jesper B Andersen, Dorthe J Strandbygård, Rune Hartmann, et al.
Journal of Hepatology|December 7, 2013
Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trendsMatthias S Matter, Thomas Decaens, Jesper B Andersen, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 25, 2017
Epigenome dysregulation in cholangiocarcinomaColm J O'Rourke, Patricia Munoz-Garrido, Esmeralda L Aguayo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2019
Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?Chiara Braconi, Stephanie Roessler, Beata Kruk, et al.
Insights Into Imaging|November 10, 2025
Critical dialogue: Can AI-based imaging predict tumor biology? Infer metastasis, microvascular invasion, and growth patterns from pixelsYashbir Singh, Gregory J Gores, Jesper B Andersen, et al.
RNA Biology|May 5, 2009
Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescenceJesper B Andersen, Krystyna Mazan-Mamczarz, Ming Zhan, et al.
Nature Reviews. Gastroenterology & Hepatology|November 1, 2019
Metabolic rearrangements in primary liver cancers: cause and consequencesLetizia Satriano, Monika Lewinska, Pedro M Rodrigues, et al.
Digestive Diseases (Basel, Switzerland)|May 13, 2016
Molecular Pathogenesis and Current Therapy in Intrahepatic CholangiocarcinomaDan Høgdall, Colm J O'Rourke, Andrzej Taranta, et al.
Expert Review of Gastroenterology & Hepatology|February 7, 2017
Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targetsDouglas V N P Oliveira, Shanshan Zhang, Xin Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Personalized Neoadjuvant Chemotherapy for Gastrointestinal Cancers: Shaping Imprecision to be PreciseDan Høgdall, Jakob V Schou, Julia Johanna Almer Bromann, et al.
Pageof 15